Related Experiment Video
Updated: Jan 12, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Lipoprotein(a) in clinical practice: What clinicians need to know
Astefanos Al-Dalakta1, Leslie S Cho2, Ashish Sarraju3
1Preventive Cardiology and Cardiac Rehabilitation, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH.
None:
Elevated lipoprotein(a) is an independent risk factor for atherosclerotic cardiovascular disease and aortic valve stenosis. Current lipid-lowering treatments have a minimal impact on lipoprotein(a) levels, but emerging therapies show promise, and ongoing phase 3 trials are evaluating their effect on cardiovascular outcomes. This review summarizes evidence on risk, screening strategies, and evolving therapies for elevated lipoprotein(a).
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Cholesterol: Significance and Regulation
Considering cholesterol and...

